EFFECT OF INHIBITORS OF GABA AMINOTRANSFERASE ON THE METABOLISM OF GABA IN BRAIN TISSUE AND SYNAPTOSOMAL FRACTIONSLOSCHER W.1981; J. NEUROCHEM.; ISSN 0022-3042; GBR; DA. 1981; VOL. 36; NO 4; PP. 1521-1527; BIBL. 30 REF.Article

COMPARATIVE STUDY OF THE INHIBITION OF GABA AMINOTRANSFERASE BY DIFFERENT ANTICONVULSANT DRUGSLOSCHER W.1980; ARCH. INTERNATION. PHARMACODYN. THERAP.; BEL; DA. 1980; VOL. 243; NO 1; PP. 48-55; BIBL. 2 P.Article

GABA IN PLASMA AND CEREBROSPINAL FLUID OF DIFFERENT SPECIES. EFFECTS OF GAMMA -ACETYLENIC GABA, GAMMA -VINYL GABA AND SODIUM VALPROATELOSCHER W.1979; J. NEUROCHEM.; GBR; DA. 1979; VOL. 32; NO 5; PP. 1587-1591; BIBL. 38 REF.Article

PHARMACOKINETICS OF SODIUM VALPROATE IN DOG AND MOUSE.LOSCHER W; ESENWEIN H.1978; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1978; VOL. 28; NO 5; PP. 782-787; ABS. ALLEM.; BIBL. 1/2 P.Article

VALPROIC ACID: BRAIN AND PLASMA LEVELS OF THE DRUG AND ITS METABOLITES, ANTICONVULSANT EFFECTS AND GAMMA -AMINOBUTYRIC ACID (GABA) METABOLISM IN THE MOUSENAU H; LOSCHER W.1982; J. PHARMACOL. EXP. THER.; ISSN 0022-3565; USA; DA. 1982; VOL. 220; NO 3; PP. 654-659; BIBL. 37 REF.Article

TRANSPORT OF GABA AT THE BLOOD-CSF INTERFACELOSCHER W; FREY HH.1982; J. NEUROCHEM.; ISSN 0022-3042; GBR; DA. 1982; VOL. 38; NO 4; PP. 1072-1079; BIBL. 2 P.Article

PHARMACOKINETICS OF DIAZEPAM IN THE DOGLOSCHER W; FREY HH.1981; ARCH. INT. PHARMACODYN. THER.; ISSN 0003-9780; BEL; DA. 1981; VOL. 254; NO 2; PP. 180-195; BIBL. 24 REF.Article

PHARMACOKINETICS OF CARBAMAZEPINE IN THE DOGFREY HH; LOSCHER W.1980; ARCH. INTERNATION. PHARMACODYN. THERAP.; BEL; DA. 1980; VOL. 243; NO 2; PP. 180-191; BIBL. 2 P.Article

New visions in the pharmacology of anticonvulsionLÖSCHER, W.European journal of pharmacology. 1998, Vol 342, Num 1, pp 1-13, issn 0014-2999Article

Valproate enhances GABA turnover in the substantia nigraLÖSCHER, W.Brain research. 1989, Vol 501, Num 1, pp 198-203, issn 0006-8993Article

γ-Acetylenic GABA antagonizes the decrease in synaptosomal GABA concentrations but not the seizures induced by 3-mercaptopropionic acid in ratsLÖSCHER, W.Biochemical pharmacology. 1986, Vol 35, Num 18, pp 3176-3180, issn 0006-2952Article

Hippocampal glutamate decarboxylase activity is not altered in gerbils with high seizure susceptibilityLÖSCHER, W.Biochemical pharmacology. 1987, Vol 36, Num 6, pp 979-982, issn 0006-2952Article

In vivo administration of valproate reduces the nerve terminal (synaptosomal) activity of GABA aminotransferase in discrete brain areas of ratsLÖSCHER, W.Neuroscience letters. 1993, Vol 160, Num 2, pp 177-180, issn 0304-3940Article

Development of tolerance to the anticonvulsant effect of GABAmimetic drugs in genetically epilepsy-prone gerbilsLÖSCHER, W.Pharmacology, biochemistry and behavior. 1986, Vol 24, Num 4, pp 1007-1013, issn 0091-3057Article

Comparison of drugs with different selectivity for central α₁- and α₂-adrenoceptors in animal models of epilepsyLOSCHER, W; CZUCZWAR, S. J.Epilepsy research. 1987, Vol 1, Num 3, pp 165-172, issn 0920-1211Article

Lesions of the deep prepiriform cortex (area tempestas) in rats do not affect the convulsant action of systemically administered bicucullineWAHNSCHAFFE, U; LOSCHER, W.Neuroscience letters. 1990, Vol 108, Num 1-2, pp 161-166, issn 0304-3940, 6 p.Article

Pharmacological evaluation of various metabolites and analogues of valproic acidLOSCHER, W; NAU, H.Neuropharmacology. 1985, Vol 24, Num 5, pp 427-435, issn 0028-3908Article

Comparative transfer of valproic acid and of an active metabolite into brain and liver : possible pharmacological and toxicological consequencesLOSCHER, W; NAU, H.Archives internationales de pharmacodynamie et de thérapie. 1984, Vol 270, Num 2, pp 192-202, issn 0003-9780Article

Chronic treatment with diazepam or the inverse benzodiazepine receptor agonist FG 7142 causes differential changes in the effects of GABA receptor stimulationLOSCHER, W; STEPHENS, D. N.Epilepsy research. 1988, Vol 2, Num 4, pp 253-259, issn 0920-1211Article

Valproic acid and active unsaturated metabolite (2-en): transfer to mouse liver following human therapeutic dosesNAU, H; LOSCHER, W.Biopharmaceutics & drug disposition. 1985, Vol 6, Num 1, pp 1-8, issn 0142-2782Article

Which animal models should be used in the search for new antiepileptic drugs? a proposal based on experimental and clinical considerationsLOSCHER, W; SCHMIDT, D.Epilepsy research. 1988, Vol 2, Num 3, pp 145-181, issn 0920-1211Article

Studies on the involvement of dopamine D-1 and D-2 receptors in the anticonvulsant effect of dopamine agonists in various rodent models of epilepsyLOSCHER, W; CZUCZWAR, S. J.European journal of pharmacology. 1986, Vol 128, Num 1-2, pp 55-65, issn 0014-2999Article

Valproic acid and metabolites: pharmacological and toxicological studiesNAU, H; LOSCHER, W.Epilepsia (Copenhagen). 1984, Vol 25, pp 14-22, issn 0013-9580, suppl. 1Article

Uncontrolled epilepsy following discontinuation of antiepileptic drugs in seizure-free patients : a review of current clinical experienceSCHMIDT, D; LÖSCHER, W.Acta neurologica scandinavica. 2005, Vol 111, Num 5, pp 291-300, issn 0001-6314, 10 p.Article

Paradoxical aggravation of paroxysmal dystonia during chronic treatment with phenobarbital in a genetic rodent modelRICHTER, A; LÖSCHER, W.European journal of pharmacology. 2000, Vol 397, Num 2-3, pp 343-350, issn 0014-2999Article